Ligand Pharmaceuticals Incorporated
LGND Healthcare Biotechnology
Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024.
- Revenue
- −31.8%
- EPS
- −123.9%
- Free cash flow
- −268.5%
- Total debt
- +52.6%
Quarter to September 2026, against a year earlier
Follow LGND
Alert me
Ligand Pharmaceuticals Incorporated (LGND) Operating margin
Ligand Pharmaceuticals Incorporated's operating margin over the twelve months to 30 September 2026 was 9.29%, down 6.0 percentage points from fiscal 2025 (15.3%). Over the past ten years it has ranged from −13.5% (fiscal 2024) to 671.0% (fiscal 2019); the current reading is higher than 36% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 15.3% | 28.82 |
| FY2024 | −13.5% | (22.62) |
| FY2023 | 9.09% | 7.54 |
| FY2022 | 1.55% | (41.44) |
| FY2021 | 43.0% | 20.06 |
| FY2020 | 22.9% | (648.06) |
| FY2019 | 671.0% | 605.88 |
| FY2018 | 65.1% | 16.86 |
| FY2017 | 48.3% | 7.98 |
| FY2016 | 40.3% | 2.27 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −20.0% | (33.50) |
| Jun 2026 | 13.5% | (20.09) |
| Mar 2026 | 33.6% | 11.14 |
| Dec 2025 | 22.4% | (25.53) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| PTCT PTC Therapeutics, Inc. compare | 12.8% |
| LGND Ligand Pharmaceuticals Incorporated | 9.29% |
| KOD Kodiak Sciences Inc. compare | 0.00% |
| ORKA Oruka Therapeutics, Inc. compare | 0.00% |
| IMVT Immunovant, Inc. compare | 0.00% |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 0.00% |
| IONS Ionis Pharmaceuticals, Inc. compare | −68.0% |
| MIRM Mirum Pharmaceuticals, Inc. compare | −133.6% |
| CGON CG Oncology, Inc. compare | −4,056.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on LGND
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement